Cases of AML with t(3;3)/inv[3] are rare and account for 1–2.5% of all AML and 1% of MDS, resulting in deregulated MECOM (also called EVI1) and GATA2 expression [5]. This evidence concerns the gene MECOM and acute myeloid leukemia.